A collaborative research team has identified a novel blood-based biomarker capable of detecting early-stage lung cancer and ...
CAT scans detecting cancer is nothing new. But now, doctors are using artificial intelligence to spot cancer even sooner.“I'm here three years later because I did find out and because I did finally ...
All study participants simultaneously underwent NGS using three sample types: (1) BWF, (2) plasma, and (3) tumor tissue collected during bronchoscopy. The full patient set (FPS) included all enrolled ...
Lung cancer remains the leading cause of cancer-related deaths in the United States, but new advances in early detection are ...
bioAffinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung ...
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...
Many eligible patients miss lung cancer screening due to low awareness and systemic barriers, putting underserved groups at higher risk for late-stage disease. She also explained the differences in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results